NeoGenomics, Inc. (NEO)
Largest Insider Buys in Sector
NEO Stock Price History Chart
NEO Stock Performance
About NeoGenomics, Inc.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
Insider Activity of NeoGenomics, Inc.
Over the last 12 months, insiders at NeoGenomics, Inc. have bought $0 and sold $201,886 worth of NeoGenomics, Inc. stock.
On average, over the past 5 years, insiders at NeoGenomics, Inc. have bought $520,710 and sold $35.5M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 17,000 shares for transaction amount of $520,710 was made by Mallon Mark (Chief Executive Officer) on 2021‑12‑06.
List of Insider Buy and Sell Transactions, NeoGenomics, Inc.
| 2024-05-15 | Sale | Olivo Alicia C | General Counsel | 1,049 0.0009% | $15.74 | $16,511 | -10.98% | |
| 2024-03-04 | Sale | TETRAULT LYNN A. | director | 6,112 0.0048% | $15.97 | $97,579 | -8.99% | |
| 2024-02-15 | Sale | Olivo Alicia C | General Counsel | 2,587 0.002% | $14.96 | $38,713 | -1.14% | |
| 2023-11-17 | Sale | Olivo Alicia C | General Counsel | 2,669 0.002% | $18.39 | $49,083 | -20.93% | |
| 2022-03-07 | Sale | Bonello William | Chief Financial Officer | 3,209 0.0026% | $18.29 | $58,693 | -43.84% | |
| 2021-12-21 | Sale | McKenzie Kathryn B | Chief Financial Officer | 1,846 0.0015% | $35.00 | $64,610 | -70.51% | |
| 2021-12-06 | Mallon Mark | Chief Executive Officer | 17,000 0.0137% | $30.63 | $520,710 | -67.38% | ||
| 2021-11-26 | Sale | Brown Douglas Matthew | Chief Strategy Officer | 33,334 0.0279% | $36.85 | $1.23M | -71.51% | |
| 2021-11-24 | Sale | Brown Douglas Matthew | Chief Strategy Officer | 33,333 0.0272% | $36.84 | $1.23M | -72.23% | |
| 2021-11-24 | Sale | Bonello William | President, Informatics | 25,000 0.0206% | $37.13 | $928,250 | -72.23% | |
| 2021-11-23 | Sale | Brown Douglas Matthew | Chief Strategy Officer | 33,333 0.0277% | $37.19 | $1.24M | -71.94% | |
| 2021-06-08 | Sale | CROWTHER BRUCE K | director | 20,734 0.0173% | $41.46 | $859,632 | -18.52% | |
| 2021-06-03 | Sale | CARDOZA GEORGE | President, Pharma Services | 31,107 0.0263% | $40.11 | $1.25M | -13.21% | |
| 2021-06-02 | Sale | CARDOZA GEORGE | President, Pharma Services | 169,230 0.1436% | $40.39 | $6.84M | -12.99% | |
| 2021-05-25 | Sale | SHOVLIN ROBERT J. | President, Clinical Services | 130,604 0.1108% | $39.31 | $5.13M | -3.93% | |
| 2020-12-14 | Sale | JONES STEVEN C | director | 25,000 0.0229% | $51.67 | $1.29M | -11.37% | |
| 2020-12-14 | Sale | Weiss Lawrence Martin | Chief Medical Officer | 20,200 0.0183% | $51.06 | $1.03M | -11.37% | |
| 2020-12-11 | Sale | JONES STEVEN C | director | 25,000 0.0229% | $50.52 | $1.26M | -8.99% | |
| 2020-12-11 | Sale | BALLIET JENNIFER | VP and Chief Culture Officer | 15,000 0.0136% | $49.99 | $749,850 | -8.99% | |
| 2020-12-10 | Sale | JONES STEVEN C | director | 20,000 0.0185% | $50.30 | $1.01M | -7.92% |
Insider Historical Profitability
| TETRAULT LYNN A. | director | 50062 0.03% | $13.28 | 2 | 3 | +1.24% |
| Olivo Alicia C | General Counsel | 44867 0.0291% | $13.28 | 0 | 3 | |
| KINDERHOOK, LP | 10 percent owner | 4848334 3.8036% | $13.28 | 5 | 0 | +67.31% |
| VAN OORT DOUGLAS M | Chairman and CEO | 2422790 1.9007% | $13.28 | 10 | 8 | +14.04% |
| DENT MICHAEL T | director | 1384150 1.0859% | $13.28 | 0 | 11 | |
| JONES STEVEN C | director | 1000000 0.7845% | $13.28 | 0 | 49 | |
| CARDOZA GEORGE | President, Pharma Services | 176772 0.1387% | $13.28 | 2 | 12 | +53.1% |
| SHOVLIN ROBERT J. | President, Clinical Services | 150101 0.1178% | $13.28 | 1 | 11 | +4.82% |
| Weiss Lawrence Martin | Chief Medical Officer | 100521 0.0789% | $13.28 | 0 | 1 | |
| Bonello William | Chief Financial Officer | 98516 0.0773% | $13.28 | 0 | 7 | |
| Mallon Mark | Chief Executive Officer | 72736 0.0571% | $13.28 | 1 | 0 | <0.0001% |
| HIPP RAYMOND R | director | 66800 0.0524% | $13.28 | 0 | 6 | |
| ALBITAR MAHER | Chief Medical Officer | 60692 0.0476% | $13.28 | 1 | 5 | +25.14% |
| Pedulla Denise E | General Counsel | 56726 0.0445% | $13.28 | 0 | 1 | |
| CROWTHER BRUCE K | director | 49564 0.0389% | $13.28 | 1 | 3 | <0.0001% |
| HANNAH ALISON L. | director | 38782 0.0304% | $13.28 | 2 | 0 | +9.16% |
| Johnson Kevin C | director | 30983 0.0243% | $13.28 | 3 | 4 | +42.62% |
| BALLIET JENNIFER | VP and Chief Culture Officer | 24980 0.0196% | $13.28 | 0 | 12 | |
| BRODIE STEVEN G. | President, Pharma Services | 15953 0.0125% | $13.28 | 0 | 2 | |
| McKenzie Kathryn B | Chief Financial Officer | 11689 0.0092% | $13.28 | 0 | 2 | |
| Brown Douglas Matthew | Chief Strategy Officer | 11644 0.0091% | $13.28 | 0 | 3 | |
| GASPARINI ROBERT P | Chief Science Officer | 8439 0.0066% | $13.28 | 0 | 14 | |
| ROSS STEVEN A | CIO | 4500 0.0035% | $13.28 | 0 | 6 | |
| SMITS MARK W | Chief Commercial Officer | 0 0% | $13.28 | 0 | 1 | |
| HOREL ROBERT H. | Vice President andGM PathLogic | 0 0% | $13.28 | 0 | 2 | |
| GENERAL ELECTRIC CO | 0 0% | $13.28 | 0 | 2 |
Institutional Investor Ownership
| BlackRock | $312.06M | 15.54 | 19.85M | -0.65% | -$2.05M | 0.01 | |
| The Vanguard Group | $223.4M | 11.13 | 14.21M | +0.29% | +$650,084.88 | <0.01 | |
| Brown Advisory | $152.01M | 7.57 | 9.67M | +0.27% | +$411,486.72 | 0.2 | |
| T Rowe Price Investment Management Inc | $107.8M | 5.37 | 6.86M | +7.44% | +$7.47M | 0.07 | |
| Janus Henderson | $98.73M | 4.92 | 6.28M | -1.07% | -$1.06M | 0.05 | |
| State Street | $76.99M | 3.84 | 4.9M | +1.09% | +$830,346.13 | <0.01 | |
| Greenhouse Funds Lllp | $69.11M | 3.44 | 4.4M | +1.46% | +$995,437.56 | 4.36 | |
| Macquarie Group | $63.25M | 3.15 | 4.02M | -1.41% | -$906,578.69 | 0.05 | |
| First Light Asset Management | $51.91M | 2.59 | 3.3M | -15.91% | -$9.82M | 4.1 | |
| Dimensional Fund Advisors | $48.84M | 2.43 | 3.11M | +3.34% | +$1.58M | 0.01 | |
| Schroder Investment Management Group | $48.8M | 2.43 | 3.1M | +25.14% | +$9.8M | 0.06 | |
| American Century Investments | $48.65M | 2.42 | 3.09M | +55.45% | +$17.35M | 0.03 | |
| Geode Capital Management | $45.77M | 2.28 | 2.91M | +2.86% | +$1.27M | <0.01 | |
| Alger | $36.78M | 1.83 | 2.34M | +24.73% | +$7.29M | 0.18 | |
| Goldman Sachs | $36.43M | 1.82 | 2.32M | +1.32% | +$476,520.36 | 0.01 | |
| Point72 Asset Management | $34.55M | 1.72 | 2.2M | New | +$34.55M | 0.07 | |
| Franklin Templeton Investments | $33.43M | 1.67 | 2.13M | +44.56% | +$10.31M | 0.01 | |
| Emerald Advisers, Inc. | $29.96M | 1.49 | 1.91M | +0.43% | +$127,174.80 | 1.22 | |
| Morgan Stanley | $28.5M | 1.42 | 1.81M | -7.7% | -$2.38M | <0.01 | |
| EMERALD MUTUAL FUND ADVISERS TRUST | $24.49M | 1.22 | 1.56M | 0% | +$0 | 1.29 | |
| Northern Trust | $24.01M | 1.2 | 1.53M | -4.47% | -$1.12M | <0.01 | |
| Segall Bryant & Hamill | $20.94M | 1.04 | 1.33M | -1.88% | -$400,168.31 | 0.39 | |
| Bank of America | $19.65M | 0.98 | 1.25M | +3.51% | +$666,779.54 | <0.01 | |
| Glenmede | $18.31M | 0.91 | 1.16M | +7.22% | +$1.23M | 0.09 | |
| Charles Schwab | $16.94M | 0.84 | 1.08M | +2.99% | +$491,281.46 | <0.01 | |
| JENNISON ASSOCIATES LLC | $16.53M | 0.82 | 1.05M | +77.77% | +$7.23M | 0.01 | |
| JPMorgan Chase | $15.4M | 0.77 | 979,371 | +23.08% | +$2.89M | <0.01 | |
| Bellevue Group | $14.87M | 0.74 | 946,025 | New | +$14.87M | 0.23 | |
| BNY Mellon | $14.74M | 0.73 | 937,852 | -4.99% | -$774,225.54 | <0.01 | |
| Oberweis Asset Management Inc | $11.59M | 0.58 | 737,200 | +87.73% | +$5.42M | 0.84 | |
| T. Rowe Price | $10.15M | 0.51 | 645,492 | +0.71% | +$71,186.23 | <0.01 | |
| Nuveen | $9.75M | 0.49 | 620,271 | -17.04% | -$2M | <0.01 | |
| ROYCE & ASSOCIATES INC | $9.04M | 0.45 | 574,897 | -2.8% | -$260,087.40 | 0.08 | |
| Ameriprise Financial | $8.5M | 0.42 | 540,581 | -3.16% | -$277,253.66 | <0.01 | |
| Invesco | $8.13M | 0.41 | 517,171 | -69.48% | -$18.51M | <0.01 | |
| Blair William Co Il | $7.43M | 0.37 | 472,870 | -1.72% | -$129,988.67 | 0.02 | |
| Ubs Asset Management Americas Inc | $6.62M | 0.33 | 421,019 | +4.28% | +$271,437.25 | <0.01 | |
| RhumbLine Advisers | $6.06M | 0.3 | 385,633 | +0.18% | +$10,909.63 | 0.01 | |
| Candriam S C A | $5.9M | 0.29 | 375,017 | +82.93% | +$2.67M | 0.04 | |
| Legal & General | $5.61M | 0.28 | 356,686 | +0.02% | +$1,163.28 | <0.01 | |
| Next Century Growth Investors LLC | $5.16M | 0.26 | 328,155 | +0.39% | +$20,105.88 | 0.45 | |
| Allianz Asset Management Gmbh | $4.41M | 0.22 | 280,621 | -1.33% | -$59,311.56 | 0.01 | |
| Jane Street Capital | $4.21M | 0.21 | 267,760 | +49.13% | +$1.39M | 0.01 | |
| Public Sector Pension Investment Board | $4.11M | 0.21 | 261,269 | -1.23% | -$50,932.80 | 0.03 | |
| Credit Suisse | $4.08M | 0.2 | 259,253 | +1.32% | +$53,227.92 | <0.01 | |
| Swiss National Bank | $3.95M | 0.2 | 251,400 | 0% | +$0 | <0.01 | |
| GW&K Investment Management | $3.58M | 0.18 | 227,923 | -3.09% | -$114,364.61 | 0.03 | |
| State of Wisconsin Investment Board | $3.48M | 0.17 | 221,514 | -8.95% | -$342,475.91 | 0.01 | |
| First Trust | $3.11M | 0.16 | 197,530 | +248.83% | +$2.21M | <0.01 | |
| Td Asset Management Inc | $3.1M | 0.15 | 197,246 | +7.2% | +$208,227.11 | <0.01 |